JANESVILLE, Wis.--(BUSINESS WIRE)--SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also ...

JANESVILLE, Wis., May 6, 2025 /PRNewswire/ -- SHINE Technologies, a nuclear fusion company with a platform of medical isotope products, announced it has entered into a definitive agreement to acquire ...

Janesville-based nuclear fusion technology company SHINE Technologies LLC announced two new board members and emphasized their experience working for public companies. Nuclear fusion technology ...

Collaboration enables access to SHINE’s supply of lutetium-177 for Nucleus RadioPharma’s radioligand therapy for neuroendocrine tumors and prostate cancer ROCHESTER, Minn. & JANESVILLE, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Shine Technologies has made a ...

SHINE Medical Technologies LLC and Phoenix LLC today announced that the companies have completed a merger under which Phoenix has become a wholly owned subsidiary of SHINE. This press release features ...

Janesville medical radioisotope startup SHINE Medical Technologies announced it has closed on a $50 million financing deal with global investment firm Oaktree Capital Management.

Chrysalis, SHINE’s large-scale irradiation facility, is set to become the largest isotope production facility in the world. Once operational, Chrysalis will complement the existing supply chain ...

JANESVILLE and FITCHBURG, Wis., April 20, 2021 – SHINE Medical Technologies LLC and Phoenix LLC today announced that the companies have completed a merger under which Phoenix has become a wholly owned ...